Trials / Completed
CompletedNCT01569646
Monocytosis and Culprit Vessel in STEMI Patients
Significance of Monocytosis and Culprit Vessel in Patients With Acute ST Elevation Myocardial Infarction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 226 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Increased white blood cell count at the onset of an acute ST elevation myocardial infarction has been shown to be associated of increased incidence of heart failure and mortality. Now monocytes which are a subset of white blood cells may have a prognostic value for patients presenting with acute ST segment elevation myocardial infarction. A monocyte count of greater than 800/mm3 following acute myocardial infarction has been shown to be associated with increased incidence of left ventricular dysfunction. The investigators study would retrospectively collect data on patients with ST elevation myocardial infarction, looking for an association between high monocyte count and the culprit vessel causing the myocardial infarction. The investigators would also investigate whether monocytosis would be a marker of poor prognosis.
Conditions
Timeline
- Start date
- 2008-04-01
- First posted
- 2012-04-03
- Last updated
- 2012-04-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01569646. Inclusion in this directory is not an endorsement.